Association of Tumor Treating Fields (TTFields) therapy with survival in newly diagnosed glioblastoma: a systematic review and meta-analysis Matthew T. BalloPatrick ConlonAaron M. Rulseh Review Open access 26 July 2023 Pages: 1 - 9
Cellular senescence in glioma Rafał ChojakJawad FaresMaciej S. Lesniak Review 17 July 2023 Pages: 11 - 29
Supramaximal versus gross total resection in Glioblastoma, IDH wild-type and Astrocytoma, IDH-mutant, grade 4, effect on overall and progression free survival: systematic review and meta-analysis Juan F. Mier-GarcÃaStefanÃa Ospina-SantaPuneet Plaha Review 10 August 2023 Pages: 31 - 41
Perivascular invasion of primary human glioblastoma cells in organotypic human brain slices: human cells migrating in human brain Rea RavinPaola Suarez-MeadeAlfredo Quiñones-Hinojosa Research 25 July 2023 Pages: 43 - 54
Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series Lorena GurrieriLaura MercataliLaura Ridolfi Research Open access 16 August 2023 Pages: 55 - 64
Long-term follow up of patients with WHO grade 2 oligodendroglioma Louise CarstamFrancesco LatiniAsgeir S. Jakola Research Open access 21 August 2023 Pages: 65 - 74
Effect of race, sex, and socioeconomic factors on overall survival following the resection of intramedullary spinal cord tumors Oluwaseun O. AkinduroAbdul Karim GhaithMohamad Bydon Research 21 July 2023 Pages: 75 - 85
Fractionated versus staged gamma knife radiosurgery for mid-to-large brain metastases: a propensity score-matched analysis Ryuichi NodaMariko KawashimaAtsuya Akabane Research 31 July 2023 Pages: 87 - 96
Molecular predictors for decitabine efficacy in meningiomas – a pilot study Dorothee C. SpilleChristian ThomasBenjamin Brokinkel Research 21 July 2023 Pages: 97 - 105
Outcome assessment of intraoperative radiotherapy for brain metastases: results of a prospective observational study with comparative matched-pair analysis Julian P. LayerMotaz HamedL. Christopher Schmeel Research Open access 21 July 2023 Pages: 107 - 116
Efficacy of intrathecal methotrexate in children with high-risk medulloblastoma over three years: a retrospective study from a single center Yu-Tong ZhangYu WangJian Chang Research Open access 20 July 2023 Pages: 117 - 125
Signal-transducing adaptor protein 1 (STAP1) in microglia promotes the malignant progression of glioma Xinyu YangChunxia JiDi Chen Research Open access 18 July 2023 Pages: 127 - 139
Hypo-fractionated accelerated radiotherapy with concurrent and maintenance temozolomide in newly diagnosed glioblastoma: updated results from phase II HART-GBM trial Supriya MallickSubhash GuptaGoura Kishor Rath Research 15 July 2023 Pages: 141 - 146
Stereotactic radiosurgery for patients with brain metastases from gastroesophageal cancers Suchet TaoriZhishuo WeiAjay Niranjan Research 20 July 2023 Pages: 147 - 155
SPOPL induces tumorigenicity and stemness in glioma stem cells by activating Notch signaling Tianyu HuRuoheng XuanZhibo Xia Research 31 July 2023 Pages: 157 - 170
Significance of O6-methyl guanine methyltransferase promoter methylation in high grade glioma patients: optimal cutoff point, CpG locus, and genetic assay Murat BuyuktepeIbrahim KaplanHasan Caglar Ugur Research 20 July 2023 Pages: 171 - 177
Phase II study of border zone stereotactic radiosurgery with bevacizumab in patients with recurrent or progressive glioblastoma multiforme Megan ManticaJan DrappatzAjay Niranjan Research 29 July 2023 Pages: 179 - 190
Tucatinib and stereotactic radiosurgery in the management of HER2 positive breast cancer brain metastases Vaseem M. KhatriMatthew N. MillsKamran A. Ahmed Research 25 July 2023 Pages: 191 - 197
Toxicity and outcomes of melanoma brain metastases treated with stereotactic radiosurgery: the risk of subsequent symptomatic intralesional hemorrhage exceeds that of radiation necrosis Paola A. JablonskaThiago MunizDavid B. Shultz Research 08 August 2023 Pages: 199 - 209
Mapping high-grade glioma immune infiltration to 5-ALA fluorescence levels: TCGA data computation, classical histology, and digital image analysis Alexandra LangRaphael L. JeronFriedrich Erhart Research Open access 06 August 2023 Pages: 211 - 220
PTPN11 variant may be a prognostic indicator of IDH-wildtype glioblastoma in a comprehensive genomic profiling cohort Ryohei OtaniMasachika IkegamiTatsuro Yamaguchi Research 08 August 2023 Pages: 221 - 229
First in-human intrathecal delivery of bevacizumab for leptomeningeal spread from recurrent glioblastoma: rationale for a dose escalation trial Matthew HoldawayFaina AblyazovaJohn A. Boockvar Research 07 August 2023 Pages: 231 - 237
Belzutifan in adults with VHL-associated central nervous system hemangioblastoma: a single-center experience Bryan J. NethMason J. WebbUgur Sener Case Study 14 July 2023 Pages: 239 - 247
Outcome of glioblastoma patients after intensive care unit admission with invasive mechanical ventilation: a multicenter analysis Bernhard NeumannJulia OnkenElisabeth Bumes Case Study Open access 02 August 2023 Pages: 249 - 256
T2-FLAIR mismatch sign correlates with 11C-methionine uptake in lower-grade diffuse gliomas Yusuke EbikoKaoru TamuraTaketoshi Maehara Case Study 17 August 2023 Pages: 257 - 265
Prognostic significance of baseline thyroid variables in IDH-wildtype glioblastoma patients treated with regorafenib Aaron Lawson McLean Correspondence Open access 10 August 2023 Pages: 267 - 268
Correction to: Radiotherapy for Atypical Teratoid/Rhabdoid Tumor (ATRT) on the Pediatric Proton/Photon Consortium Registry (PPCR) Andrew RoehrigDaniel J. IndelicatoTorunn I. Yock Correction 27 July 2023 Pages: 269 - 269
